POPULARITY
8 episodes with community acquired pneumonia
8 episodes with community acquired pneumonia
3 episodes with community acquired pneumonia
3 episodes with community acquired pneumonia
2 episodes with community acquired pneumonia
5 episodes with community acquired pneumonia
2 episodes with community acquired pneumonia
2 episodes with community acquired pneumonia
2 episodes with community acquired pneumonia
0:16 Intro 2:29 Updated community-acquired pneumonia guidelines 5:41 Diagnostic tools for CAP following COVID-19 9:35 Procalcitonin levels as a biomarker 12:30 The CAP treatment algorithm 18:36 Best practices for antibiotic stewardship 20:40 New CAP therapies on the horizon 22:36 ACIP recommendations for vaccination 24:30 Remaining areas of CAP uncertainty 26:30 Final thoughts 27:25 Outro Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs' due to antimicrobial resistance. Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
In this episode, we review the high-yield topic of Community-Acquired Pneumonia from the Infectious Disease section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets
In this episode, Dr. Zanotti is joined by Dr. Stephen Pastores to discuss the 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia, published by the Society of Critical Care Medicine. Dr. Pastores is Program Director for Critical Care Medicine and Vice-Chair of Education for the Department of Anesthesiology and Critical Care Medicine at Memorial Sloan Kettering Cancer Center. In addition, Dr. Pastores is a professor of anesthesiology and medicine at Weill Cornell Medical College in New York, NY. Additional resources: 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Medicine 2024: https://journals.lww.com/ccmjournal/pages/articleviewer.aspx?year=9900&issue=00000&article=00275&type=Fulltext Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. ADRENAL Trial. N Engl J Med 2018. https://www.nejm.org/doi/full/10.1056/NEJMoa1705835 Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. APROCCHSS Clinical Trial. N Engl J of Med 2018: https://www.nejm.org/doi/full/10.1056/NEJMoa1705716 Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomized controlled trial. The Lancet 2020: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30417-5/abstract Hydrocortisone in Severe Community-Acquired Pneumonia. CAPE-COD Trial. N Eng J Med 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215145 Books mentioned in this episode: Elon Musk. By Walter Isaacson: https://bit.ly/3PVXWsG The Autumn Ghost: How the Battle Against a Polio Epidemic Revolutionized Modern Medical Care. By Hannah Wunsch: https://bit.ly/4avevns
Community acquired pneumonia is unfortunately a common condition seen in children of all ages. Dr. Jacob Eichenberger, an associate professor of pediatrics at MCG and a pediatric hospitalist at the Children's Hospital of Georgia, joins recently graduated pediatric resident, Dr. Fahim Thawer, and medical student Sara Attari to discuss the evaluation and management of community acquired pneumonia. Specifically, they will: • Discuss common history and physical exam findings associated with community acquired pneumonia • Formulate a differential diagnoses • Work through the initial diagnostic approach and treatment • Discuss prognosis and prevention
A look Pneumonia, including Community vs Hospital Acquired Pneumonia and the pathophysiology. We also cover the signs and symptoms as well as the diagnosis, Pneumonia treatment and the main antibiotics used. Consider subscribing on YouTube (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Pneumonia? 0:55 Community Acquired Pneumonia 1:47 Hospital Acquired Pneumonia 2:25 Pneumonia Pathophysiology3:28 Pneumonia Symptoms (Signs and Symptoms) 4:14 Pneumonia Diagnosis5:51 Pneumonia Treatment ReferencesSethi, S - MSD Manual Pro (2022) Overview of Pneumonia. Available at*:* https://www.msdmanuals.com/professional/pulmonary-disorders/pneumonia/overview-of-pneumoniaNICE (2019) Pneumonia (hospital-acquired): antimicrobial prescribing. Available at https://www.nice.org.uk/guidance/ng139BMJ Best Practice (2022) Pneumonia (Overview). Available at https://bestpractice.bmj.com/topics/en-gb/1113Raghavendra R. Sanivarapu; Joshua Gibson (2023) Aspiration Pneumonia. Available at https://www.ncbi.nlm.nih.gov/books/NBK470459/Vardhmaan Jain; Rishik Vashisht; Gizem Yilmaz; Abhishek Bhardwaj (2023) Pneumonia Pathology. Available at https://www.ncbi.nlm.nih.gov/books/NBK526116/Please remember this podcast and all content from Rhesus Medicine is meant for educational purposes only and should not be used as a guide to diagnose or to treat. Please consult a healthcare professional for medical advice.
Each month, EMedHome.com presents EMCast, the 90-minute podcast hosted by Dr. Amal Mattu, the premier educator in Emergency Medicine. Subscribe to EMedHome.com for an array of clinical content that will impact every shift. This month's EMCast covers:(1) ED Use of Sodium Bicarbonate(2) Migraine Headache(3) Community Acquired Pneumonia
Event Objectives:Become familiar with new evidence for the management of community acquired pneumonia.Understand how to improve your antimicrobial stewardship in management of community pneumonia by decreasing unnecessary use of broad spectrum antibiotics and prescribing antibiotics for the shortest effective duration.Learn about free Connecticut Children's resources available to outpatient pediatric providers to keep up to date with the management of community acquired pneumonia and other infectious diseases.Resources:https://www.connecticutchildrens.org/clinical-pathways/https://app.firstline.org/en/clients/187-connecticut-childrensClaim CME Credit Here!
Howie and Harlan are joined by Melinda Pettigrew of the Yale School of Public Health to discuss the changes needed in the prescription and agriculture use of antibiotics to address the crisis of antimicrobial resistance. Harlan reports on a survey underlining the scale of medical misinformation among Americans; Howie discusses a new tool for the treatment of unhoused people. Links: Medical Misinformation Harlan Krumholz: “A prescription for the US FDA for the regulation of health misinformation” “Vaccine Confidence Falls as Belief in Health Misinformation Grows” Annenberg Public Policy Center of the University of Pennsylvania: Annenberg Science and Public Health (ASAPH) Panel, August 9-15, 2023” Melinda Pettigrew and Antimicrobial Resistance “Melinda Pettigrew—The next dean of SPH!” “New Law Will Help Combat Growing Threat of Antibiotic Resistance” “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children” "Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia" “Two Yale alum tackle infection diagnostics” “A Review of the Effectiveness of Current US Policies on Antimicrobial Use in Meat and Poultry Production” FDA Fact Sheet: Veterinary Feed Directive Final Rule and Next Steps CDC: Measuring Outpatient Antibiotic Prescribing Treating the Unhoused “Housing Supply and the Drivers of Homelessness” CMS: Place of Service Code Set “New place of service code for treating unsheltered people” Rough Sleepers “‘You Have to Learn to Listen': How a Doctor Cares for Boston's Homeless” VA: VA Homeless Programs Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.
Howie and Harlan are joined by Melinda Pettigrew of the Yale School of Public Health to discuss the changes needed in the prescription and agriculture use of antibiotics to address the crisis of antimicrobial resistance. Harlan reports on a survey underlining the scale of medical misinformation among Americans; Howie discusses a new tool for the treatment of unhoused people. Links: Medical Misinformation Harlan Krumholz: “A prescription for the US FDA for the regulation of health misinformation” “Vaccine Confidence Falls as Belief in Health Misinformation Grows” Annenberg Public Policy Center of the University of Pennsylvania: Annenberg Science and Public Health (ASAPH) Panel, August 9-15, 2023” Melinda Pettigrew and Antimicrobial Resistance “Melinda Pettigrew—The next dean of SPH!” “New Law Will Help Combat Growing Threat of Antibiotic Resistance” “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children” "Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia" “Two Yale alum tackle infection diagnostics” “A Review of the Effectiveness of Current US Policies on Antimicrobial Use in Meat and Poultry Production” FDA Fact Sheet: Veterinary Feed Directive Final Rule and Next Steps CDC: Measuring Outpatient Antibiotic Prescribing Treating the Unhoused “Housing Supply and the Drivers of Homelessness” CMS: Place of Service Code Set “New place of service code for treating unsheltered people” Rough Sleepers “‘You Have to Learn to Listen': How a Doctor Cares for Boston's Homeless” VA: VA Homeless Programs Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.
Today's episode is on the inpatient workup and management of Community-Acquired Pneumonia featuring an admission checklist, HPI intake, differential, plan, and high-yield clinical pearls. Visit pointofcaremedicine.com to see the templates, pearls, literature, and other resources discussed in this episode. Our mission is to create accessible and easy-to-use digital resources that help healthcare professionals tackle common clinical presentations at the point of care without getting bogged down by unnecessary details or trivia. Show Notes: 00:00:08 - Background and Definitions 00:01:13 - Etiology and Pathophysiology 00:02:49 - Admission Checklist 00:05:16 - HPI Intake 00:06:38 - Physical Exam Findings 00:07:30 - Differential 00:08:48 - Treatment Plan 00:10:15 - If You Remember Nothing Else 00:11:47 - Clinical Pearls - Etiology 00:13:47 - Clinical Pearls - Presentation and Diagnosis 00:16:53 - Clinical Pearls - Treatment 00:19:52 - Clinical Pearls - Complications
The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Show notes at pharmacyjoe.com/episode856. In this episode, I’ll discuss the consensus statement published in CHEST on the Treatment of Community-Acquired Pneumonia in immunocompromised patients. The post 856: Treatment of Community-Acquired Pneumonia in immunocompromised patients appeared first on Pharmacy Joe.
The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Show notes at pharmacyjoe.com/episode856. In this episode, I’ll discuss the consensus statement published in CHEST on the Treatment of Community-Acquired Pneumonia in immunocompromised patients. The post 856: Treatment of Community-Acquired Pneumonia in immunocompromised patients appeared first on Pharmacy Joe.
In this episode, we discuss the controversy surrounding the usage of steroids in Community-acquired pneumonia. This controversy arose after the CAPE-COD trial was published recently in NEJM. We discuss the pros and cons of administering steroids as a blanket treatment. We recommend caution and suggest considering the external validity of this trial before changing your practices.
Full article: https://www.ajronline.org/doi/10.2214/AJR.23.29414 Shambo Guha Roy, MD discusses an article in which the authors developed a deep learning model to predict 30-day mortality of community acquired pneumonia from chest radiographs.
On this episode, we discuss the various treatment options for community acquired pneumonia. We compare and contrast the differences in treating a patient with and without comorbidities in the outpatient setting as well as non-severe and severe CAP in the inpatient setting. We also review some basics for the various antibiotics used in CAP. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below: www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
Severe community‐acquired pneumonia (sCAP) is a clinical entity to describe ICU-admitted patients with community‐acquired pneumonia (CAP) as they might require organ support, and it is associated with high morbidity and mortality. While European and non‐European guidelines are available for CAP, there are no specific guidelines for sCAP. Therefore, a team of experts have joined efforts to prepare a summary document to guide the most effective treatments and management strategies for adult patients with sCAP. Listen to the following podcast to learn more about these guidelines produced by the European Respiratory Society (ERS), the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Latin American Thoracic Association (ALAT).Original paper: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaSpeakersIgnacio MARTIN-LOECHES. Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin (IE). Antoni TORRES. CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid (ES). Pedro PÓVOA. NOVA Medical School, CHRC, New University of Lisbon (PT).
The NP is seeing a 65-year-old woman who is a former smoker, having quit at age 40, with a 20 pack-year cigarette smoking history, and has been diagnosed with community-acquired pneumonia (CAP). Which of the following is most often noted CAP finding in an adult who is deemed to be appropriate for outpatient treatment? A. Pleuritic chest painB. DyspneaC. Purulent sputum productionD. Cough---YouTube: https://www.youtube.com/watch?v=lQDnrmJjOLw&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=17Visit fhea.com to learn more!
This piece focuses upon the “REMAP-CAP” trial; A Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia. It's a wide ranging discussion which looks behind the headlines of this fascinating piece of research. Their website is here: https://www.remapcap.org/ In the podcast you will hear Monty Mythen speaking with Steve Webb, Professor of Critical Care Research at Monash University, Director of Research for St John of God Healthcare, and a ICU consultant at St John of God Subiaco and the Mount Hospital and Doug Campbell, Anaesthetic specialist at Auckland City Hospital.
Episode Notes This month, University of Kentucky HealthCare PGY2 Infectious Diseases Pharmacy Residents Becca and Kam are on their DASON rotation and are talking to DASON Digest listeners about Hydrocortisone use in severe CAP. The article reviewed in this episode is available here: https://pubmed.ncbi.nlm.nih.gov/36942789/ For more information about DASON, please visit: https://dason.medicine.duke.edu/
In this episode, we discuss recently published RCT, which demonstrated the mortality benefit in Community-acquired pneumonia.
Show Notes: https://eddyjoemd.com/hydrocortisone-cap/ In this episode of the podcast, I discuss a new study that found that hydrocortisone can save lives in patients with severe community-acquired pneumonia (CAP). I discuss the findings and what they mean for the treatment of CAP. In addition I also discuss the risks and benefits of using hydrocortisone, and who should be considered for treatment. CAP is a common and potentially life-threatening infection of the lungs. It is caused by bacteria that are inhaled into the lungs, and it can affect people of all ages. The most common symptoms of CAP are fever, cough, shortness of breath, and chest pain. In severe cases, CAP can lead to pneumonia, sepsis, and death. The study that we discuss in this episode was a randomized controlled trial that looked at the effect of hydrocortisone on mortality in patients with severe CAP. The study found that patients who received hydrocortisone were less likely to die than those who did not receive hydrocortisone. This finding is significant because it suggests that hydrocortisone may be a life-saving treatment for patients with severe CAP. We hope that you find this episode of the podcast informative and helpful. If you have any questions or comments, please feel free to contact me. Citation: Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefève G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, François B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L'Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengellé C, Caille-Fénérol C, Giraudeau B, Le Gouge A; CRICS-TriGGERSep Network. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023 Mar 21. doi: 10.1056/NEJMoa2215145. Epub ahead of print. PMID: 36942789. My website: www.eddyjoemd.com Instagram: www.instagram.com/eddyjoemd Twitter: www.twitter.com/eddyjoemd Facebook: www.facebook.com/eddyjoemd Podcast: https://anchor.fm/eddyjoemd My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd --- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support
Recommendations for the use of steroids in community-acquired pneumonia have been mixed. This episode reviews a large multicenter randomized trial in the New England Journal of Medicine by Dequin et al on hydrocortisone for severe community-acquired pneumonia. References/show notes: FOAMcast.org Thanks for listening! Lauren Westafer
Roger Seheult, MD of MedCram explores a new RCT study that shows a 48% reduction in mortality in severe community acquired pneumonia when patients receive intravenous hydrocortisone. See all Dr. Seheult's videos at: https://www.medcram.com (This video was recorded on March 26, 2023) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #hydrocortisone #pneumonia #RCT
In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the impact of respiratory syncytial virus (RSV) and describe those at risk for severe RSV disease, including: RSV prevalence and seasonality RSV burden throughout life, including burden in older adultsComorbidities that increase the risk of RSV complications RSV transmission in the hospital and care home settingImplications of risk factors for severe RSV on prevention and treatment Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkHelen Y. Chu, MD, MPHAssociate Professor of MedicineDivision of Allergy & Infectious DiseasesUniversity of Washington School of MedicineSeattle, WashingtonLink to full program: bit.ly/3nb25xeLink to downloadable slides: bit.ly/3TsXym5
Caitlin C. Schanz, PharmD (@Schanz_Caitlin) explains the pharmacological mechanism of steroid use in community-acquired pneumonia treatment, interprets literature assessing use of steroids in management of community-acquired pneumonia and relates efficacy and safety outcomes of steroids in community-acquired pneumonia to a patient case. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
In this episode, Dr Rizzo interviews Hariharan Regunath, MD, about community-acquired pneumonia (CAP), including updates to the American Thoracic Society and Infectious Diseases Society of America guidelines on the diagnosis and treatment of adults with CAP, the use of the pneumonia severity index, the CURB-65 prediction tools to help decide the need for hospitalization, diagnostic tests, and more.
The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Show notes at pharmacyjoe.com/episode751. In this episode, I'll discuss why the CAP guidelines do not recommend treating most cases of suspected aspiration pneumonia with broadening antibiotic therapy. The post 751: Does aspiration pneumonia require different antibiotics than community acquired pneumonia? appeared first on Pharmacy Joe.
The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Show notes at pharmacyjoe.com/episode751. In this episode, I ll discuss why the CAP guidelines do not recommend treating most cases of suspected aspiration pneumonia with broadening antibiotic therapy. The post 751: Does aspiration pneumonia require different antibiotics than community acquired pneumonia? appeared first on Pharmacy Joe.
In this presentation Dr Avent will share results from a quality improvement study, conducted in remote and regional paediatric inpatient facilities, testing a package of intervention tools to promote the IV to oral conversion of antibiotic therapy for children with Community Acquired Pneumonia and skin and soft tissue infections. Onsite training was provided during the implementation period and continued with telehealth support for the intervention phase from a multi-disciplinary research team from the Queensland Statewide Antimicrobial Stewardship Program and the Antimicrobial Stewardship Program based at the Queensland Children's Hospital. Clinicians could tailor the tools to their practice setting and patient's requirements, which is more realistic of a real-world situation. In addition, the uptake of the intervention materials was supported by onsite paediatric clinical champions at each facility.
Date: February 7th, 2022 Reference: Williams et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the scout-cap randomized clinical trial. JAMA Pediatrics 2022 Guest Skeptic: Dr. Dennis Ren is a pediatric emergency medicine fellow at Children's National Hospital in Washington, DC. Case: A three-year-old boy presents to the emergency department (ED) with fever […]
Lower respiratory tract infections are still the world's most fatal communicable disease. Community acquired pneumonia specifically is one of the most common infections managed by clinicians in daily practice. On this episode of Microbe Mail, host Dr Vindana Chibabhai speaks to Pulmonologist, Dr Erica Shaddock about diagnosing and managing CAP. About our Guest: Erica Shaddock is a specialist Pulmonologist Pulmonologist at Charlotte Maxeke Johannesburg Academic Hospital since 2009. Her special interests include COPD, Pneumonia , PCP and Covid-19. She is currently registered for her PhD focussing in the immune response and modulation in Pneumocystis pneumonia patients . She has been an integral member of the Covid-19 team at the Charlotte Maxeke Johannesburg Academic Hospital. She is also a senior lecturer in the Department of Internal Medicine at the University of the Witwatersrand. Visit the Microbe Mail https://microbemail.captivate.fm/ (website) to sign up for updates E-mail: mail.microbe@gmail.com YouTube: https://www.youtube.com/channel/UCgaP3aUNkjrgOxR8Ei6UaEw (Microbe Mail) Instagram: https://instagram.com/https:/www.instagram.com/microbe_mail/ (Microbe_Mail) South African Community Acquired pneumonia guidelines https://jtd.amegroups.com/article/view/13850/html (here) Access “Gender differences in community acquired pneumonia” article https://pubmed.ncbi.nlm.nih.gov/32166931/ (here)
This episode features Dr. Angelina Davis from DASON. The article reviewed in this episode is available here: https://doi.org/10.1016/S0140-6736(21)00313-5. For more information about DASON, please visit: https://dason.medicine.duke.edu.
Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the November 2, 2021 issue.
In this podcast, Francisco Sanz, MD, PhD, talks about his session at CHEST 2021, during which he discussed preventing community-acquired pneumonia through vaccinating against pneumococcal disease, influenza, and COVID-19. More at: www.consultant360.com
Today we'll be covering Community-Acquired Pneumonia, going along with this month's theme, Infectious Disease- Chest Infections. If you haven't listened to our podcast before, each week we have a case-based discussion about a medical topic to help you study for the pediatric medicine board exam. Episodes are released every weekend, and the case is then reviewed and reinforced on social media throughout the week. Follow the podcast on social media: Facebook- @portablepeds (www.facebook.com/portablepeds) Twitter- @portablepeds (www.twitter.com/portablepeds) We'd love to hear from you via email at portablepeds@gmail.com! Also, feel free to visit our website, www.portablepeds.com, for more content. Today's Case: An 18 month old previously healthy male presents to your primary care clinic for cough. Father reports patient has had fever, cough, nasal congestion, rhinorrhea, and difficulty breathing for the past 24 hours. On physical exam, patient has nasal congestion, active cough, mild suprasternal retractions, and faint diffuse crackles. Pulse oximetry is 98% on room air. You suspect the patient has pneumonia, and you also obtain a rapid influenza test, which is positive. What is the next best step? Send the patient to the Emergency Department now for likely admission Obtain PA and Lateral Chest X-ray Start Amoxicillin Start Azithromycin Start Oseltamivir We would like to give an enormous thank you to Zack Goldmann for designing this podcast's logo and accompanying artwork. You can find more of his work at www.zackgoldmann.com. The intro and outro of this podcast is a public domain song obtained from scottholmesmusic.com. Intro/Outro- Hotshot by Scott Holmes Disclaimer: This podcast is intended for healthcare professionals. The information presented is for general educational purposes only and should NOT be used as professional medical advice or for the diagnosis or treatment of medical conditions. The views and opinions expressed do not represent the views and opinions of our employer or any affiliated institution. Expressed opinions are based on specific facts, under certain conditions, and subject to certain assumptions and should not be used or relied upon for any other purpose, including, but not limited to, the diagnosis or treatment of medical conditions or in any legal proceeding. Full terms and conditions can be found at portablepeds.com. Thanks for listening! As always, please Rate and Review this podcast on Apple Podcasts, Facebook, or your favorite podcasting platform. Also, Subscribe to get all the latest episodes, and Share this episode with someone you think would enjoy it! Hope to see you real soon!
In this episode, we review the high-yield topic of Community-Acquired Pneumonia from the Infectious Disease section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets
A new antibiotic may allow outpatient treatment for higher-risk patients with pneumonia. Oral 5-Day Lefamulin for Outpatient Management of Community-Acquired Bacterial Pneumonia: Post-hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Trial
EMplify - February 2021 Community Acquired Pneumonia - An Interview with Dr. Matthew DeLaney, FACEP 1. Pneumonia and nomenclature : healthcare associated vs hospital associated2. COVID-19 and antibiotics3. Bacteriology - Strep is only 10-15% of hospitalized pneumonia, Viral pneumonia is about 20% (pre covid)4. Conditions that predispose to pneumonia chronic lung disease (chronic obstructive pulmonary disease, bronchiectasis) smoking older age immuno-compromise proton-pump inhibitors, H2 blockers, and antipsychotic agents 5. Is there a historical or exam item most likely to be indicative of pneumonia?6. How good is a CXR?7. When should I consider a CT if the CXR is normal?8. Procalcitonin9. Blood cultures, sputum cultures, urine antigens- are these helpful?10. CURB-65 vs PSI11. Antibiotics- table 3 major and minor, history of prior infection, and doxy for everyone !12. Duration - 5 days works13. A walk through the pathway
“Ons land is totaal niet voorbereid op een pandemie, echt dramatisch” In de tweede aflevering van SignaalWaarde spreken Marino, Yorick, en Maarten met arts-microbioloog en epidemioloog prof.dr. Marc Bonten over de Nederlandse strategie, de opkomst van nieuwe varianten, alles rondom vaccins en vaccineren, en ze beantwoorden vragen van de luisteraars. Je kunt nu ook Vriend van de Show worden! Het is ook mogelijk op een andere manier bij te dragen aan de podcast. Tijdschema 00:03:10 - Een snelle start - “Dit gaat helemaal fout” 00:08:07- Strategie & zero covid 00:19:14 - Een blik op de toekomst 00:27:12 - Testen en infectiepreventie 00:34:00 - Vaccinatie - “elke spuit moet meteen in een arm” 00:47:29 - Sociale epidemiologie - “Er is elke week een ander dilemma” 00:52:21 - De komende 6 maanden 00:54:49 - De persoonlijke noot - “de schoonheid van de REMAP-CAP” 01:01:31 - Afkondiging Links Het paper van 23 januari over het reproductiegetal van het nieuwe coronavirus. En een beschouwing en het blog: “it giet oan”. De situatie in IJsland en Nieuw Zeeland. Het OMT advies over de R van 0,9 van 28 september: “Het OMT ziet een R(t) van 0,9 als bovengrens. (...) het [is] verstandig naar een lagere R(t) te streven en eerder een steviger pakket aan maatregelen te adviseren.” Thijs Kuiken die schrijft over aviaire influenza (vogelgriep). Over internationale samenwerkingen om betere behandelingen te vinden: REMAP-CAP study (A Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia). RECOVER en PERPARE. PRINCIPLE study in primary care. WHO solidarity trial. Mooi overzicht van alle verschillende varianten bij Nextstrain. De CureVac trial in Nederland. Samenwerken in One Health. Contact Je kan ons altijd vragen stellen en suggesties doen via onze website signaalwaarde.nl maar we zijn natuurlijk ook te bereiken via Twitter: @signaalwaarde. Daarnaast kun je ons altijd mailen op signaalwaarde@gmail.com
In this episode, we talk about the microbiology, clinical manifestations and treatment of one of the oldest diseases in the books - Pneumonia!
Dr. Olga Klinkova, Infectious Diseases Clinician at the Moffitt Cancer Center and Research Institute, discusses the recent updates to the diagnosis and management of community acquired pneumonia. Dr. Klinkova begins her talk by referring to the recently introduced IDSA-ATS guidelines, released in August, 2019. She then discusses updates in the microbiology of CAP, including the most likely organisms, the role of MRSA, atypicals and the significance of viral pathogens. She then mentions diagnostic modalities and the relevance of clinical prediction algorithms such as CURB-65 and the Pneumonia Severity Index (PSI). Treament considerations including outpatient versus inpatient, and inpatient non-severe versus inpatient severe management are also differentiated. Specific treatment agents and therapy durations are also mentioned. Lastly, she discusses options for the management of MRSA pneumonia and aspiration syndromes.
This week we dive into a recent article highlighting a major update in the treatment of community acquired pneumonia (CAP) https://media.blubrry.com/coreem/content.blubrry.com/coreem/Podcast_Episode_156_0_Final_Cut.m4a Download Leave a Comment Tags: CAP, Macrolides, Pulmonary Show Notes Read More REBEL EM: Update in Community Acquired Pneumonia (CAP) Treatment – Macrolide Resistance
In 2015, community acquired pneumonia (CAP) accounted for 15% of deaths in children under 5 years old globally and 922 000 deaths globally in children of all ages. In this podcast Iram Haq, a registrar and clinical research associate in paediatric respiratory medicine, joins us to discuss the definition of pneumonia, how to assess for the infection, and what treatments are effective. Read the full clinical update: http://www.bmj.com/content/356/bmj.j686
Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It's hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, for ... The post REPLAY: Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV appeared first on Healthy Debate.
Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It's hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, for ...The post REPLAY: Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV appeared first on Healthy Debate.
Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It's hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, ...The post Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV appeared first on Healthy Debate.
Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It's hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, ... The post Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV appeared first on Healthy Debate.
Aired April 23: Empiric antibiotic choices for community acquired pnuemonia and clindamycin versus trimethoprim-sulfamethoxazole for skin and soft tissue infections. Fahad and Amol want you to understand the following: 1. A large, high quality RCT showed that there was no significant difference between an empiric treatment strategy of beta-lactam vs beta-lactam plus macrolide vs respiratory fluoroquinolone for ... The post Summer Replay: Community Acquired Pneumonia and Skin Infections appeared first on Healthy Debate.
Aired April 23: Empiric antibiotic choices for community acquired pnuemonia and clindamycin versus trimethoprim-sulfamethoxazole for skin and soft tissue infections. Fahad and Amol want you to understand the following: 1. A large, high quality RCT showed that there was no significant difference between an empiric treatment strategy of beta-lactam vs beta-lactam plus macrolide vs respiratory fluoroquinolone for ...The post Summer Replay: Community Acquired Pneumonia and Skin Infections appeared first on Healthy Debate.
This week: Empiric antibiotic choices for community acquired pnuemonia and clindamycin versus trimethoprim-sulfamethoxazole for skin and soft tissue infections. Fahad and Amol want you to understand the following: 1. A large, high quality RCT showed that there was no significant difference between an empiric treatment strategy of beta-lactam vs beta-lactam plus macrolide vs respiratory fluoroquinolone for the ...The post The Antibiotics Jam: Community Acquired Pneumonia and Skin Infections appeared first on Healthy Debate.
© 2020-2025 Ivy Podcast Discovery LLC
